We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+30.65%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$1.22B
AUM Growth
+$447M
Cap. Flow
+$296M
Cap. Flow %
24.24%
Top 10 Hldgs %
33.48%
Holding
131
New
39
Increased
28
Reduced
28
Closed
25

Top Buys

Rank Stock Value
1
Z icon
Zillow
Z
+$22.6M
2
QCOM icon
Qualcomm
QCOM
+$17.4M
3
XYZ
Block Inc
XYZ
+$12.7M
4
CVNA icon
Carvana
CVNA
+$11.3M
5
FIVE icon
Five Below
FIVE
+$11.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.56%
2 Technology 21.36%
3 Consumer Discretionary 16.81%
4 Communication Services 9.68%
5 Industrials 2.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
51
Regeneron Pharmaceuticals
REGN
$80.8B
$7.95M 0.65%
14,200
+1,700
+14% +$1.03M
CARR icon
52
Carrier Global
CARR
$52.8B
$7.91M 0.65%
+259,000
New +$7.33M
SRPT icon
53
Sarepta Therapeutics
SRPT
$1.77B
$7.58M 0.62%
54,000
-6,000
-10% -$912K
BATRK icon
54
Atlanta Braves Holdings Series B
BATRK
$3.21B
$7.52M 0.62%
358,000
-21,000
-6% -$407K
RUN icon
55
Sunrun
RUN
$2.46B
$7.24M 0.59%
+94,000
New +$4.42M
CWH icon
56
Camping World
CWH
$653M
$7.04M 0.58%
236,700
-6,300
-3% -$206K
AZEK
57
DELISTED
The AZEK Co
AZEK
$7.04M 0.58%
202,100
+49,400
+32% +$1.72M
NYT icon
58
New York Times
NYT
$10.2B
$6.93M 0.57%
162,000
+44,500
+38% +$1.95M
BMRN icon
59
CALL
BioMarin Pharmaceuticals
BMRN
$12.4B
$6.85M 0.56%
90,000
VMC icon
60
PUT
Vulcan Materials
VMC
$36.9B
$6.78M 0.56%
+50,000
New +$6.28M
LII icon
61
Lennox International
LII
$15.2B
$6.54M 0.54%
+24,000
New +$6.41M
NVTA
62
CALL
DELISTED
Invitae Corporation
NVTA
$6.5M 0.53%
150,000
RARE icon
63
Ultragenyx Pharmaceutical
RARE
$2.55B
$6.46M 0.53%
78,600
-400
-0.5% -$33.2K
TT icon
64
Trane Technologies
TT
$106B
$6.43M 0.53%
+53,000
New +$5.95M
TRUP icon
65
PUT
Trupanion
TRUP
$1.18B
$5.92M 0.48%
75,000
-5,000
-6% -$300K
INFN
66
DELISTED
Infinera Corporation Common Stock
INFN
$5.75M 0.47%
+934,000
New +$6.54M
KRTX
67
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$5.68M 0.47%
73,500
-1,500
-2% -$128K
IPHI
68
DELISTED
INPHI CORPORATION
IPHI
$5.44M 0.45%
+48,500
New +$5.66M
EB
69
CALL
DELISTED
Eventbrite
EB
$5.37M 0.44%
+495,000
New +$4.92M
U icon
70
Unity
U
$18.9B
$5.24M 0.43%
+60,000
New +$5.06M
MGNX icon
71
MacroGenics
MGNX
$257M
$5.11M 0.42%
203,000
+1,000
+0.5% +$27.3K
HOLX
72
DELISTED
Hologic
HOLX
$4.79M 0.39%
+72,000
New +$4.56M
MDC
73
DELISTED
M.D.C. Holdings, Inc.
MDC
$4.68M 0.38%
107,244
FROG icon
74
JFrog
FROG
$10.8B
$4.4M 0.36%
+52,000
New +$3.87M
NVTA
75
DELISTED
Invitae Corporation
NVTA
$4.33M 0.36%
+100,000
New +$3.41M

Similar funds

Atika Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Atika Capital Management held 131 positions worth $1.22B, up 58% from $774M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Atika Capital Management deployed $296M of net new capital in Q3 2020, opening 39 new positions and adding to 28 existing holdings. Its largest new stake was Zillow: 290,000 shares worth $29.5M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was CATALENT, INC., an estimated $8.96M trimmed.

  • Atika Capital Management's largest Q3 2020 buy was Zillow: 290,000 shares worth $29.5M.
  • Atika Capital Management added most to Carvana in Q3 2020, an estimated $11.3M increase.
  • Atika Capital Management's biggest Q3 2020 reduction was CATALENT, INC., cutting an estimated $8.96M.
  • Atika Capital Management fully exited eHealth in Q3 2020, selling an estimated $12M.
  • Atika Capital Management's ten largest holdings make up 33% of its $1.22B portfolio in Q3 2020.
  • Atika Capital Management opened 39 new positions and closed 25 in Q3 2020.
  • Atika Capital Management's portfolio value rose 58% quarter-over-quarter to $1.22B.

Based on Atika Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.